Greenland Mines Ltd operates as a natural resources company. It focuses on the exploration and development of Skaergaard Project in Southeast Greenland. The company is also involved in the development of KLTO-202, a cell and gene therapy for amyotrophic lateral sclerosis. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.